In the present study, we demonstrated that SHP2 functions as a key modulator of the proliferation of breast cancer cells by promoting the G1-to-S phase transition through regulating Cyclin D1 stability via the PI3K/AKT/GSK3β signaling pathway. This evidence concerns the gene AKT1 and breast carcinoma.